|
ACAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.678150E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.047900E-04 |
| Normal-vs-Stage2 |
1.067800E-01 |
| Normal-vs-Stage3 |
6.833000E-01 |
| Normal-vs-Stage4 |
8.864800E-01 |
| Stage1-vs-Stage2 |
9.713200E-01 |
| Stage1-vs-Stage3 |
6.043600E-03 |
| Stage1-vs-Stage4 |
1.935540E-03 |
| Stage2-vs-Stage3 |
1.695030E-01 |
| Stage2-vs-Stage4 |
1.278360E-01 |
| Stage3-vs-Stage4 |
7.958600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.976500E-03 |
| Normal-vs-AfricanAmerican |
7.112400E-01 |
| Normal-vs-Asian |
2.226400E-01 |
| Caucasian-vs-AfricanAmerican |
1.275820E-02 |
| Caucasian-vs-Asian |
4.672000E-01 |
| AfricanAmerican-vs-Asian |
7.463800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.517700E-02 |
| Normal-vs-Female |
9.915700E-03 |
| Male-vs-Female |
2.967000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.764600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.576700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.827760E-01 |
| Normal-vs-Age(81-100Yrs) |
7.862600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.264200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.586800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.766600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.809700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.940100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.488600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.584100E-04 |
| Normal-vs-Grade 2 |
4.373100E-04 |
| Normal-vs-Grade 3 |
3.398800E-01 |
| Normal-vs-Grade 4 |
5.503200E-01 |
| Grade 1-vs-Grade 2 |
2.988200E-01 |
| Grade 1-vs-Grade 3 |
1.880900E-03 |
| Grade 1-vs-Grade 4 |
2.382200E-03 |
| Grade 2-vs-Grade 3 |
1.259230E-03 |
| Grade 2-vs-Grade 4 |
3.016500E-04 |
| Grade 3-vs-Grade 4 |
1.364780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71172999999802E-05 |
| Normal-vs-ccB subtype |
3.016800E-01 |
| ccA subtype-vs-ccB subtype |
3.573800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.572240E-02 |
| Normal-vs-N1 |
7.223800E-01 |
| N0-vs-N1 |
5.584200E-01 |
|
|
